FDA Approves Nivolumab for Some Metastatic Colorectal Cancers

| August 17, 2017 | 0 Comments
FDA Approves Nivolumab for Some Metastatic Colorectal Cancers

FDA has granted accelerated approval to the immunotherapy drug nivolumab (Opdivo®) for patients with metastatic colorectal cancer whose tumors have alterations that affect DNA repair.
See Original Article

Category: Recent News

About the Author ()

Leave a Reply